FRIST CRESSEY VENTURES MANAGEMENT, LLC
FRIST CRESSEY VENTURES MANAGEMENT, LLC is a Seed, Series A, Series B and Series C+ fund in the US writing $1M–$60M checks into AI and healthcare-tech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- AI, healthcare-tech
- Check size
- $1M–$60M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $1.423B
- Website
- fcventures.com
Thesis
Headquartered in Nashville, Tennessee, with an office in New York, FCV exclusively targets healthcare innovation. Their investment thesis centers on enhancing care quality, optimizing healthcare economics, improving accessibility, and reducing health inequities, with a strong emphasis on AI-native business models. They invest across primary care, specialty care, oncology, behavioral health, and palliative care. FCV typically invests in companies from the seed through Series B stages, often taking a lead investor role, with check sizes ranging from $1 million to $60 million. As of February 2026, the firm closed its oversubscribed Fund IV at $425 million, bringing its total AUM to nearly $1 billion.
Common questions
Does FRIST CRESSEY VENTURES MANAGEMENT, LLC invest at the Seed stage?
Yes. FRIST CRESSEY VENTURES MANAGEMENT, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does FRIST CRESSEY VENTURES MANAGEMENT, LLC write?
FRIST CRESSEY VENTURES MANAGEMENT, LLC writes $1M–$60M checks.
Where does FRIST CRESSEY VENTURES MANAGEMENT, LLC invest?
FRIST CRESSEY VENTURES MANAGEMENT, LLC invests in the US.